Back to top
more

Integer Holdings (ITGR)

(Delayed Data from NYSE)

$102.69 USD

102.69
437,265

-0.38 (-0.37%)

Updated Sep 17, 2025 04:00 PM ET

After-Market: $102.72 +0.03 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (93 out of 245)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Hill-Rom (HRC) Q3 Earnings Top Estimates, Margins Expand

by Zacks Equity Research

Hill-Rom (HRC) registers a solid year-over-year revenue rise on strong domestic growth, driven by a robust performance at Patient Support Systems and Surgical Solutions.

    Zacks Equity Research

    ITGR vs. ABMD: Which Stock Is the Better Value Option?

    by Zacks Equity Research

    ITGR vs. ABMD: Which Stock Is the Better Value Option?

      Zacks Equity Research

      Zimmer Biomet (ZBH) Q2 Earnings Top Estimates, Margins Drop

      by Zacks Equity Research

      The improvement within Zimmer Biomet's (ZBH) global Knee and Hip sales performance and ongoing growth within the Asia Pacific region are encouraging.

        Zacks Equity Research

        GNC Holdings (GNC) Q2 Earnings Beat, Revenues Miss Mark

        by Zacks Equity Research

        Though GNC Holdings' (GNC) domestic retail comps are slightly weaker than expected, the company performs strongly in e-commerce business and at International segment.

          Zacks Equity Research

          Baxter (BAX) Q2 Earnings Beat Estimates, Revenues Rise Y/Y

          by Zacks Equity Research

          Baxter (BAX) gains on the back of its core Renal Care segment in Q2; solid international sales encourage.

            Zacks Equity Research

            Zacks.com highlights: Hitachi, Integer Holdings, Panasonic and SunCoke Energy

            by Zacks Equity Research

            Zacks.com highlights: Hitachi, Integer Holdings, Panasonic and SunCoke Energy

              Zacks Equity Research

              Align Technology (ALGN) Beats on Earnings and Revenues in Q2

              by Zacks Equity Research

              Align Technology (ALGN) gains on solid contributions from Clear Aligner as well as Scanner and Service segments in Q2.

                Zacks Equity Research

                Chemed (CHE) Beats on Q2 Earnings & Revenues, View Raised

                by Zacks Equity Research

                Chemed (CHE) rides on strong contributions from the Roto-Rooter and VITAS businesses in Q2.

                  Zacks Equity Research

                  Stryker (SYK) Beats on Q2 Earnings, International Sales Up

                  by Zacks Equity Research

                  Stryker (SYK) gains from solid segmental performance in Q2.

                    Zacks Equity Research

                    Medidata (MDSO) Q2 Earnings Beat, Revenues Miss Estimates

                    by Zacks Equity Research

                    Medidata (MDSO) gains from solid segmental performance in Q2; banks on strategic buyouts.

                      Zacks Equity Research

                      Boston Scientific (BSX) Beats on Q2 Earnings, Margins Down

                      by Zacks Equity Research

                      Boston Scientific (BSX) registers steady growth across all business lines and geographies in Q2.

                        Zacks Equity Research

                        Look Beyond Earnings: 4 Stocks With Increasing Cash Flows

                        by Zacks Equity Research

                        Cash is indispensable to any company. It gives strength and vitality to a company and is the key to its existence, development and success.

                          Zacks Equity Research

                          Zacks.com highlights: Integer Holdings, Stars Group, Turtle Beach, FTI Consulting, and Yatra Online

                          by Zacks Equity Research

                          Zacks.com highlights: Integer Holdings, Stars Group, Turtle Beach, FTI Consulting, and Yatra Online

                            Zacks Equity Research

                            5 Stocks in Focus on New Analyst Coverage

                            by Zacks Equity Research

                            Increased analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.

                              Zacks Equity Research

                              Quest Diagnostics (DGX) Q2 Earnings Meet, Guidance Narrowed

                              by Zacks Equity Research

                              Quest Diagnostics (DGX) gains on successful execution of its two-point strategy of accelerating growth and driving operational excellence in Q2.

                                Nalak Das headshot

                                5 Low-Beta Stocks to Combat Trade & Geopolitical Tensions

                                by Nalak Das

                                The United States and China are yet to reach any sort of understanding to defuse trade tensions between the countries.

                                  Zacks Equity Research

                                  Merit Medical (MMSI) Beats on Q2 Earnings, Raises Guidance

                                  by Zacks Equity Research

                                  Merit Medical (MMSI) gains from solid segmental performance in Q2; lifts 2018 guidance.

                                    Zacks Equity Research

                                    Zacks.com highlights: Integer Holdings, SunCoke Energy, SHISEIDO, Weight Watchers International and Triton International

                                    by Zacks Equity Research

                                    Zacks.com highlights: Integer Holdings, SunCoke Energy, SHISEIDO, Weight Watchers International and Triton International

                                      Zacks Equity Research

                                      PetMed (PETS) Q1 Earnings Lag Estimates, Reorder Sales Solid

                                      by Zacks Equity Research

                                      We are encouraged by growth in PetMed's (PETS) reorder and new order sales in Q1. Increased online sales buoy optimism.

                                        Zacks Equity Research

                                        5 Top Stocks With a Handsome Net Profit Margin

                                        by Zacks Equity Research

                                        Five stocks with spectacular net profit margin that can contribute to making a winning portfolio.

                                          Zacks Equity Research

                                          Intuitive Surgical (ISRG) Beats on Q2 Earnings & Revenues

                                          by Zacks Equity Research

                                          Strong performance in the Instruments & Accessories as well as Systems segments drove Intuitive Surgical's (ISRG) top line in Q2.

                                            Zacks Equity Research

                                            Neogen (NEOG) Earnings and Revenues Beat Estimates in Q4

                                            by Zacks Equity Research

                                            Neogen (NEOG) sticks to its four-pronged growth strategy for steady progress. Also, the company's accretive buyouts and its broader international base are a boon.

                                              Zacks Equity Research

                                              Abbott (ABT) Q2 Earnings & Revenues Top Estimates, View Up

                                              by Zacks Equity Research

                                              Abbott (ABT) posts another quarter of strong EPD and Medical Devices performance. Particularly, Abbott has been riding high on a healthy growth within its Diabetes Care business.

                                                Zacks Equity Research

                                                OPKO Health's RAYALDEE Gets Approval in Canada to Treat CKD

                                                by Zacks Equity Research

                                                OPKO Health's (OPK) partner VFMCRP gets regulatory nod from Health Canada to market flagship RAYALDEE; benefits patients diagnosed with chronic kidney disease.

                                                  Zacks Equity Research

                                                  Zacks.com featured highlights include: Integer Holdings, Louisiana-Pacific, Knight-Swift, Herc and Eaton

                                                  by Zacks Equity Research

                                                  Zacks.com featured highlights include: Integer Holdings, Louisiana-Pacific, Knight-Swift, Herc and Eaton